News

Paul Bruhn Joins Hofseth BioCare ASA as New Business Head

Paul Bruhn Joins Hofseth BioCare ASA as New Business Head

Hofseth BioCare ASA Welcomes Paul Bruhn as Head of Development

Hofseth BioCare ASA (Oslo:HBC) is thrilled to share the exciting news of Paul Bruhn's appointment as the new Head of New Business Development. With over 25 years of experience in healthcare and medical nutrition, Bruhn brings a wealth of knowledge that aligns perfectly with the company’s vision.

Extensive Experience in Healthcare and Nutrition

Mr. Bruhn’s impressive background includes leadership roles at industry giants like Novartis Medical Nutrition and Nestle Health Science, where he operated across various key regions such as Asia, the Middle East, and Australia. His global perspective and expertise in clinical nutrition and consumer healthcare make him a valuable addition to Hofseth BioCare.

A Vision for Innovation

In his new role, Bruhn emphasizes the growing demand for clinically-backed nutrition solutions. He highlights Hofseth BioCare's specialty ingredients as essential for meeting market needs. "I am eager to contribute to taking HBC to new heights, especially as we amplify our business in Asia and across the ANZ region," Bruhn stated.

Unique Bioactive Ingredients from HBC

Hofseth BioCare has established itself as a pioneer in developing a unique portfolio of bioactive ingredients. Their products, including OmeGo®, ProGo®, NT-II™, and PetGo®, are derived from sustainably sourced salmon. Unlike conventional fish oils, OmeGo® is a full-spectrum salmon oil that ensures all beneficial Omega fatty acids are preserved, promoting heart health and providing anti-inflammatory benefits.

Commitment to Sustainability and Health

As a leading Norwegian company, Hofseth BioCare prioritizes sustainability and optimal resource utilization. The company specializes in transforming waste from the salmon industry into valuable health ingredients. By upcycling side streams, HBC not only contributes to environmental sustainability but also enhances the well-being of humans and pets.

Scientific Backing and Health Benefits

Hofseth BioCare's ingredients are supported by scientific research and partnerships with academia. For instance, ProGo® has shown promise in improving iron metabolism, increasing energy, and supporting vitality. Similarly, OmeGo® has been linked to enhanced immune function and improved sleep in individuals affected by pollution.

Patents and Future Innovations

HBC’s innovative work has led to multiple patents that protect their groundbreaking discoveries, paving the way for potential therapeutics. The company has recently established HBC Immunology, focused on biotech developments for serious health conditions, including prostate and ovarian cancer.

What Lies Ahead for Hofseth BioCare?

With Bruhn at the helm of new business development, there are high expectations for Hofseth BioCare's future initiatives and product innovations. The company's commitment to creating high-quality and scientifically backed health solutions aligns with the growing consumer demand for transparent and effective nutrition sources.

Contact Information

For more insights, please reach out to:

James Berger, CCO at Hofseth BioCare ASA
Phone: +41 79 950 1034
E-mail: jb@hofsethbiocare.no

About Hofseth BioCare ASA

Founded on the principles of sustainability and traceability, Hofseth BioCare ASA leads the way in valuing all parts of the salmon. Their innovative approach not only fosters environmental stewardship but also prioritizes consumer health with unique, bioactive ingredients designed for the next generation.

Frequently Asked Questions

Who is Paul Bruhn?

Paul Bruhn is the newly appointed Head of New Business Development at Hofseth BioCare ASA, bringing over 25 years of experience in healthcare.

What are the main products offered by Hofseth BioCare?

Hofseth BioCare offers a range of bioactive ingredients including OmeGo®, ProGo®, NT-II™, and PetGo®, all derived from sustainably sourced salmon.

How does Hofseth BioCare prioritize sustainability?

The company emphasizes upcycling salmon industry by-products to create health ingredients, ensuring full utilization of natural resources and sustainability.

What are the health benefits of OmeGo®?

OmeGo® provides a full spectrum of Omega fatty acids, promoting heart health, reducing inflammation, and offering significant immune health benefits.

Where is Hofseth BioCare located?

Hofseth BioCare's headquarters are in Ålesund, Norway, with additional branches in Oslo, London, Zürich, Los Angeles, and Palo Alto.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Eli Lilly's Pirtobrutinib Shows Promising Results in CLL Trials

Updated Category News Views 158

Pirtobrutinib's Efficacy in Chronic Lymphocytic Leukemia Studies Eli Lilly and Company (NYSE: LLY) made notable advancements in chronic lymphocytic leukemia (CLL) research with their drug, pirtobrutinib. The recent study, known as BRUIN CLL-321, demonstrated that pirtobrutinib significantly reduced the risk of disease progression or death by 46% compared to previous...

Continue Reading
Exploring Axon Enterprise's Options Trading Dynamics

Updated Category News Views 173

Investors' Insights on Axon Enterprise In the ever-evolving world of stock market investments, insights from institutional and wealthy individual investors can carry significant weight. Recently, there has been a noticeable bullish stance on Axon Enterprise (NASDAQ: AXON), raising curiosity among retail traders about potential future movements. Unusual Options Activity...

Continue Reading
Aventis Energy Releases Technical Report on Corvo Project

Updated Category News Views 143

Aventis Energy Files NI 43-101 Technical Report on Corvo Project Aventis Energy Inc. (“Aventis” or the “Company”) (CNSX: AVE | Frankfurt: C0O0 | Other OTC: VBAMF) is excited to announce that its partner, Standard Uranium Ltd., has filed a technical report detailing findings and exploration data from the Corvo Project. This report, titled "Technical Report on the...

Continue Reading
Drucker + Falk Celebrates Community Commitment Through Cleanup Events

Updated Category News Views 108

Drucker + Falk's Dedication to Community Engagement Drucker + Falk, a prominent name in multifamily property management, has made remarkable strides in community involvement through its annual clean-up initiatives. This year, they marked the third consecutive clean-up campaign aimed at enhancing local environments, aligning their efforts with the mission of Keep America...

Continue Reading
Exploring the Future of Mental Health: The Wholeness Center

Updated Category News Views 96

Revolutionizing Mental Health with Integrative Approaches The Wholeness Center has gained state approval to offer legal psilocybin-assisted therapy, marking a significant milestone as the sole licensed healing center in Northern Colorado. This innovative facility combines the realms of psychedelic therapy with integrative psychiatry, aiming to provide comprehensive mental...

Continue Reading